| Ticker Details |
Omnicell, Inc.
Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing.
|
| IPO Date: |
August 7, 2001 |
| Sector: |
Healthcare |
| Industry: |
Health Care Technology |
| Market Cap: |
$1.62B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.66 | 1.78%
|
| Avg Daily Range (30 D): |
$0.98 | 2.42%
|
| Avg Daily Range (90 D): |
$0.91 | 2.21%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.3M |
| Avg Daily Volume (30 D): |
.65M |
| Avg Daily Volume (90 D): |
.54M |
| Trade Size |
| Avg Trade Size (Sh.): |
82 |
| Avg Trade Size (Sh.) (30 D): |
52 |
| Avg Trade Size (Sh.) (90 D): |
48 |
| Institutional Trades |
| Total Institutional Trades: |
6,526 |
| Avg Institutional Trade: |
$2.63M |
| Avg Institutional Trade (30 D): |
$2.39M |
| Avg Institutional Trade (90 D): |
$2.99M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.4M |
| Avg Closing Trade (30 D): |
$4.08M |
| Avg Closing Trade (90 D): |
$4.81M |
| Avg Closing Volume: |
57.95K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$.85
|
$.53
|
$.25
|
|
Diluted EPS
|
$.84
|
$.52
|
$.25
|
|
Revenue
|
$1.25B
|
$312.21M
|
$309.88M
|
|
Gross Profit
|
$558.13M
|
$152.94M
|
$140.36M
|
|
Net Income / Loss
|
$39.08M
|
$24.29M
|
$11.36M
|
|
Operating Income / Loss
|
$57.96M
|
$32.45M
|
$16.85M
|
|
Cost of Revenue
|
$688.58M
|
$159.27M
|
$169.52M
|
|
Net Cash Flow
|
$-108.75M
|
$31.79M
|
$39.93M
|
|
PE Ratio
|
|
|
|
|
|
|
